In NAFLD rat model induced by an HFD, oral administration of FSN improved HNF4-α/lipin-1 signaling, lowered oxidative stress, and suppressed reactive oxygen species-induced TXNIP induction and PARP-1 activation [34]. This evidence concerns the gene PARP1 and metabolic dysfunction-associated steatotic liver disease.